Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 USD | +5.13% | 0.00% | -17.73% |
Feb. 28 | Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Nautilus Biotechnology, Inc.
Upcoming events on Nautilus Biotechnology, Inc.
Past events on Nautilus Biotechnology, Inc.
2024-03-06 01:30 pm | TD Cowen Health Care Conference |
2024-02-28 08:30 am | Q4 2023 Earnings Call |
2024-02-28 08:00 am | Q4 2023 Earnings Release |
2023-10-31 08:30 am | Q3 2023 Earnings Call |
2023-10-31 08:05 am | Q3 2023 Earnings Release |
2023-09-21 10:30 am | Gilmartin Group Emerging Growth Company Showcase |
2023-09-13 10:50 am | Morgan Stanley Global Healthcare Conference |
2023-08-14 | UBS Genomics 2.0 and MedTech Innovations Summit |
2023-08-10 10:00 am | Canaccord Genuity Growth Conference - Panel |
2023-08-02 08:30 am | Q2 2023 Earnings Call |
2023-08-02 07:30 am | Q2 2023 Earnings Release |
2023-06-14 01:00 pm | Annual General Meeting |
2023-06-12 07:40 pm | Goldman Sachs Global Healthcare Conference |
2023-06-08 01:00 pm | Jefferies Global Healthcare Conference |
2023-05-02 08:30 am | Q1 2023 Earnings Call |
2023-05-02 06:30 am | Q1 2023 Earnings Release |
2023-04-06 01:30 pm | B. Riley Securities Disruptive Biotech Enabling Technologies Conference - Fireside Chat |
2023-03-06 02:50 pm | Cowen Health Care Conference |
2023-02-23 08:30 am | FY 2022 Earnings Call |
2023-02-23 06:05 am | FY 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,20 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -41,5 -47,8 13.13% | -52,0 -66,0 21.13% | -62,2 -72,1 13.78% | -88,1 |
EBIT Million USD | Released Forecast Spread | 0,00 | -50,5 -51,1 1.2% | -63,6 -66,7 4.67% | -76,2 -77,6 1.87% | -97,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -50,3 -50,3 -0.03% | -57,9 -62,1 6.72% | -63,7 -72,3 11.93% | -94,7 |
Net income Million USD | Released Forecast Spread | -15,6 | -50,3 -50,3 -0.03% | -57,9 -62,1 6.72% | -63,7 -72,3 11.93% | -94,7 |
EPS USD | Released Forecast Spread | 0,00 | -0,60 -0,70 14.29% | -0,46 -0,50 8% | -0,51 -0,58 12.07% | -0,75 |
Announcement Date | 26/03/21 | 24/02/22 | 23/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,17 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 1,30 |
EBITDA Million USD | Released Forecast Spread | -14,0 -14,6 3.95% | -13,6 -18,2 25.1% | -12,6 -19,0 33.56% | -12,6 -20,1 37.11% | -13,1 -25,4 48.33% | -14,8 -15,3 3.17% | -15,5 -15,4 -0.5% | -15,5 -18,6 16.66% | -16,4 -18,8 12.91% | -17,2 | -18,7 | -20,7 | -23,1 | -21,8 |
EBIT Million USD | Released Forecast Spread | -16,8 -16,0 -5.32% | -16,0 -18,8 14.78% | -15,5 -20,3 23.78% | -15,8 -18,4 14.02% | -16,3 -19,2 15.23% | -18,1 -18,8 3.77% | -19,0 -20,0 4.76% | -19,1 -21,4 10.66% | -20,0 -20,7 3.53% | -21,8 | -23,4 | -25,3 | -27,4 | -26,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,7 -16,7 0.07% | -15,8 -20,0 21.19% | -14,7 -21,4 31.36% | -14,1 -17,9 21.22% | -13,4 -17,5 23.38% | -15,0 -19,6 23.45% | -15,8 -20,2 21.74% | -15,9 -21,5 26.15% | -17,0 -19,4 12.02% | -20,5 | -22,3 | -24,5 | -27,3 | -27,9 |
Net income Million USD | Released Forecast Spread | -16,7 -16,7 0.07% | -15,8 -20,0 21.19% | -14,7 -21,4 31.36% | -14,1 -17,9 21.22% | -13,4 -17,5 23.38% | -15,0 -19,6 23.45% | -15,8 -20,2 21.74% | -15,9 -21,5 26.15% | -17,0 -19,4 12.02% | -20,5 | -22,3 | -24,5 | -27,3 | -27,9 |
EPS USD | Released Forecast Spread | -0,13 -0,13 0% | -0,13 -0,16 18.75% | -0,12 -0,17 29.41% | -0,11 -0,15 24.14% | -0,11 -0,14 21.43% | -0,12 -0,16 22.58% | -0,13 -0,14 7.14% | -0,13 -0,12 -8.33% | -0,14 -0,15 6.67% | -0,16 | -0,18 | -0,20 | -0,22 | -0,22 |
Announcement Date | 24/02/22 | 03/05/22 | 02/08/22 | 01/11/22 | 23/02/23 | 02/05/23 | 02/08/23 | 31/10/23 | 28/02/24 | - | - | - | - | - |
Past sector events for Nautilus Biotechnology, Inc.
2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NAUT Stock
- Calendar Nautilus Biotechnology, Inc.